APA Alıntı

Thapa, B., Caimi, P. F., Ardeshna, K. M., Solh, M., Carlo-Stella, C., Kahl, B. S., & Hamadani, M. (2020). CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy. Blood Adv.

Chicago Stili Alıntı

Thapa, Bicky, Paolo F. Caimi, Kirit M. Ardeshna, Melhem Solh, Carmelo Carlo-Stella, Brad S. Kahl, ve Mehdi Hamadani. "CD19 Antibody-drug Conjugate Therapy in DLBCL Does Not Preclude Subsequent Responses to CD19-directed CAR T-cell Therapy." Blood Adv 2020.

MLA Alıntı

Thapa, Bicky, et al. "CD19 Antibody-drug Conjugate Therapy in DLBCL Does Not Preclude Subsequent Responses to CD19-directed CAR T-cell Therapy." Blood Adv 2020.